Compound Detail
CHEMBL3779944
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
COc1cc2c(cc1OC)CN(CCc1ccc(-n3cc(COc4ccccc4NC(=O)c4ccccc4)nn3)cc1)CC2
Basic Information
| ChEMBL ID | CHEMBL3779944 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | MTZFMAOBMQJWLH-UHFFFAOYSA-N |
1
Targets
2
Activities
2
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
589.7
MW (Da)
5.72
ALogP
8
HBA
1
HBD
90.7
PSA (Ų)
0.21
QED
2
Ro5 Violations
11
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 1 meas. best 6.32
IC50 1 meas. best 5.78
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | EC50 | = | 483.6 | nM | 6.32 | Reversal of P-gp-mediated resistance to adriamycin in human K562/A02 cells asses... | 27073052 |
| Unchecked | IC50 | = | 1650.0 | nM | 5.78 | Reversal of P-gp-mediated resistance to adriamycin in human K562/A02 cells asses... | 27073052 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 27073052 | 10.1016/j.bmc.2016.03.065 | Unchecked | 3 |
| 27073052 | 10.1016/j.bmc.2016.03.065 | ADMET | 1 |
| 27073052 | 10.1016/j.bmc.2016.03.065 | K562 | 1 |
Data from ChEMBL 36 via Core Engine